Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 13/20 | 0.83 |
| ▸ | GRIN2B | Q13224 | 13/20 | 0.83 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.69 |
| ▸ | VDR | P11473 | 1/20 | 0.69 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.69 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.69 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.69 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7011421 | 1.00 | GRIN1 (0.83) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL14941193 | 1.00 | GRIN1 (0.83) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL15921398 | 1.00 | GRIN1 (0.83) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL14941061 | 1.00 | GRIN1 (0.83) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL15921397 | 1.00 | GRIN1 (0.83) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL19253197 | 0.91 | GRIN1 (1.00) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL15796049 | 0.89 | GRIN1 (0.87) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL2392478 | 0.89 | GRIN1 (0.87) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL15994082 | 0.89 | GRIN1 (0.87) | GRIN1GRIN2BABCC4VDRGRIN2D | |
| SCHEMBL2392476 | 0.89 | GRIN1 (0.87) | GRIN1GRIN2BABCC4VDRGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3321686-B1 | BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME | METABOLON INC (US) | 2024-03-13 | — | — | EP | disclosed |
| US-20180203021-A1 | Biomarkers Related to Insulin Resistance Progression and Methods Using the Same | METABOLON, INC. | 2018-07-19 | — | — | US | disclosed |
| EP-3321686-A1 | BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-2951313-B1 | BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME | METABOLON INC (US) | 2018-03-07 | — | — | EP | disclosed |
| EP-2951313-A1 | BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2015-12-09 | — | — | EP | disclosed |
| US-20140296134-A1 | METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-10-02 | — | — | US | disclosed |
| EP-2776829-A1 | METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION | The Board of Regents of The University of Texas System (US) | 2014-09-17 | — | — | EP | disclosed |
| WO-2014120449-A1 | BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME | METABOLON, INC. (US) | 2014-08-07 | — | — | WO | disclosed |
| US-20140156573-A1 | METHODS FOR GENERATING PREDICTIVE MODELS FOR EPITHELIAL OVARIAN CANCER AND METHODS FOR IDENTIFYING EOC | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2014-06-05 | — | — | US | disclosed |
| WO-2013188333-A1 | BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-12-19 | — | — | WO | disclosed |
| WO-2013070962-A1 | METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-05-16 | — | — | WO | disclosed |